Key facts
- Althea (Outcome Management (Healthcare))’s last known valuation is $4.5M (Aug 2024).
- It has raised $2.5M; the latest was Early Stage VC ($1.0M) in Nov 2025.
- Notable investors include Matchstick Ventures, Boulder Ventures, Break Trail Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Althea (Outcome Management (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Althea (Outcome Management (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Althea (Outcome Management (Healthcare))
Developer of research tools designed to manage the introduction of regulated psychedelics into healthcare settings. The company's tool provides functionalities for patient intake, treatment management, clinical study integration, and data collection, enabling healthcare providers, research institutions, and pharmaceutical companies to comply with regulations, track patient outcomes, and advance the understanding of psychedelics as therapeutic agents.
- Sector
- Healthcare
- HQ
- Boulder, CO, United States
- Founded
- 2024
- Employees
- 8
- Website
- withalthea.com/
- Ownership
- Privately Held (backing)
Althea (Outcome Management (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Althea (Outcome Management (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Althea (Outcome Management (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.